Science Explorer Back to mapMap
Discussion
Topic · Cardiology and Cardiovascular Medicine

Cardiomyopathy and Myosin Studies

Cardiomyopathy and Myosin Studies is a research topic within Cardiology and Cardiovascular Medicine. Science Explorer counts 40k research works in it since 1950. 10.0% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the diagnosis, management, genetic basis, and clinical outcomes of hypertrophic cardiomyopathy. It explores topics such as cardiomyopathies, myosin mutations, left ventricular non-compaction, sudden death risk, cardiac imaging, titin mutations, dilated cardiomyopathy, and cardiac fibrosis.

  • Cardiomyopathies
  • Genetic Mutations
  • Myosin
  • Left Ventricular Non-Compaction
  • Sudden Death Risk
  • Cardiac Imaging
  • Titin Mutations
  • Dilated Cardiomyopathy
  • Clinical Outcome
  • Cardiac Fibrosis
Research works
40k
fractional, since 1950
In the world top 10%
4k
per year above
Top-10% rate
10.0%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+18%
the tick is no change
Largest producer
United States
44% of the 10 largest, 2022-now
Cardiomyopathy and Myosin Studies

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Cardiomyopathy and Myosin Studies research?

By volume, the United States and China publish the most (2.3k and 781 works in 2022-now).

By volume, 2022-now

  1. 1 United States 2.3k works
  2. 2 China 781 works
  3. 3 Italy 429 works
  4. 4 United Kingdom 372 works
  5. 5 Japan 293 works
  6. 6 Germany 278 works
  7. 7 India 209 works
  8. 8 France 199 works
  9. 9 Spain 190 works
  10. 10 Canada 175 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 43.9%China: 15.0%Italy: 8.2%United Kingdom: 7.1%6 others listed: 25.8%44%largest
United States2,289 · 43.9%China781 · 15.0%Italy429 · 8.2%United Kingdom372 · 7.1%6 others listed1,344 · 25.8%

Shares of the rows listed above, not of the whole node.

Which institutions lead Cardiomyopathy and Myosin Studies research?

By volume in 2022-now, Mayo Clinic publishes the most Cardiomyopathy and Myosin Studies research, followed by Harvard University and Chinese Academy of Medical Sciences & Peking Union Medical College.

By volume, 2022-now

  1. 1 Mayo ClinicUnited States 99 works
  2. 2 Harvard UniversityUnited States 87 works
  3. 3 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 81 works
  4. 4 University of PennsylvaniaUnited States 56 works
  5. 5 Russian Academy of SciencesRussia 45 works
  6. 6 Cleveland ClinicUnited States 45 works
  7. 7 University College LondonUnited Kingdom 44 works
  8. 8 The Ohio State UniversityUnited States 40 works
  9. 9 Stanford UniversityUnited States 40 works
  10. 10 Johns Hopkins UniversityUnited States 39 works

Who are the leading researchers in Cardiomyopathy and Myosin Studies?

The most-cited researchers publishing on Cardiomyopathy and Myosin Studies include George Davey Smith, Mark J. Daly and Stacey L. Gabriel.

  1. 1 George Davey Smith United Kingdom 435k citations
  2. 2 Mark J. Daly United States 403k citations
  3. 3 Stacey L. Gabriel United States 402k citations
  4. 4 John J.V. McMurray United Kingdom 349k citations
  5. 5 Shizuo Akira Japan 342k citations
  6. 6 Emelia J. Benjamin United States 341k citations
  7. 7 Valery L. Feigin New Zealand 341k citations
  8. 8 Stephan Windecker Switzerland 338k citations
  9. 9 Gregory Y.H. Lip United Kingdom 311k citations
  10. 10 Matthias Mann Germany 308k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Cardiomyopathy and Myosin Studies?

The most cited paper in Cardiomyopathy and Myosin Studies is "Cardiac excitation–contraction coupling" (Donald M. Bers, 2002), with 4,798 citations. Next come "The Regulation of Rabbit Skeletal Muscle Contraction" (4,539) and "2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy" (4,371).

Most cited papers
#PaperReleasedCitations
1 Cardiac excitation–contraction coupling Donald M. Bers · Nature 2002 4,798
2 The Regulation of Rabbit Skeletal Muscle Contraction James A. Spudich, Susan Watt · Journal of Biological Chemistry Open access Aug 1971 4,539
3 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy Authors Task Force Members et al. · European Heart Journal Open access105 authors 29 Aug 2014 4,371
4 A Novel Paradigm for Heart Failure With Preserved Ejection Fraction Walter J. Paulus, Carsten Tschöpe · Journal of the American College of Cardiology Open access 15 May 2013 3,567
5 Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy Sue C. Bodine, Esther Latres, Susanne Baumhueter et al. · Science Open access 23 Nov 2001 3,550
All 98 most cited papers, with filters and sorting

Where is Cardiomyopathy and Myosin Studies research done?

The largest centres of Cardiomyopathy and Myosin Studies research in 2022-now are London (United Kingdom), Beijing (China), New York (United States) and Tokyo (Japan). Among places with at least 20 works in it, it is an unusually large share of all research in Scottsdale and Rochester.

Largest cities, 2022-now

  1. 1 LondonUnited Kingdom 178 works
  2. 2 BeijingChina 167 works
  3. 3 New YorkUnited States 112 works
  4. 4 TokyoJapan 89 works
  5. 5 ParisFrance 89 works
  6. 6 BostonUnited States 88 works
  7. 7 PhiladelphiaUnited States 88 works
  8. 8 MoscowRussia 81 works
  9. 9 RomeItaly 69 works
  10. 10 São PauloBrazil 67 works

Where it is the local speciality

  1. ScottsdaleUS · 46.2 works14×
  2. RochesterUS · 29.0 works11×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Cardiomyopathy and Myosin Studies than the world average.

See Cardiomyopathy and Myosin Studies on the map

Where is the best place to study Cardiomyopathy and Myosin Studies?

Among universities, judged by research, Harvard University, University of Pennsylvania and Stanford University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%mean 17.45%fractional works in this field (log) →share of work in the world top 10% →Harvard UniversityUniversity of Pennsy…University College L…Stanford University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 91.320.1%4.5×87 +17.6%
2University of PennsylvaniaUnited States 79.717.9%8.7×56 +86.8%
3Stanford UniversityUnited States 73.312.9%4.5×40 +41.7%
4University College LondonUnited Kingdom 70.515.5%4.5×44 -2.6%
5Johns Hopkins UniversityUnited States 68.911.7%4.2×40 +45.9%
6Tufts UniversityUnited States 66.819.6%10.1×28 -8.2%
7Maastricht UniversityNetherlands 66.723.4%4.8×12 +72.8%
8University of OxfordUnited Kingdom 66.517.6%2.9×24 +10.4%
9Radboud University NijmegenNetherlands 65.723.2%3.8×14 +34.1%
10University of WashingtonUnited States 62.912.6%5.0×34 +62.2%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Cardiomyopathy and Myosin Studies, country by country

Is Cardiomyopathy and Myosin Studies research growing?

Output in 2022-2025 was 18% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Cardiomyopathy and Myosin Studies.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Cardiomyopathy and Myosin Studies as a percentage of every work published that year, 0.029% in 2024.

still counting0.025%0.050%0.075%Cardiomyopathy and Myosin Studies0.031% in 202519801990200020102020

Fractional works of Cardiomyopathy and Myosin Studies over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Cardiomyopathy and Myosin Studies10.1% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Cardiomyopathy and Myosin Studies. Posts are plain text and can be reported.